title: [When is expensive pharmacotherapy good value for the money?].
abstract: Expensive drugs are good value for money if they are effective and safe, and if they have a better cost-effectiveness ratio than the standard therapy. In this article, an overview of commonly used methods, sources and functions of health economic evaluation is presented and illustrated using clinical examples to facilitate interpretation of the health economic information.
authors.affiliation: Fachgebiet Management im Gesundheitswesen, Technische Universität Berlin. annette.riesberg@tu-berlin.de
authors.forename: A
authors.initials: A
authors.lastname: Riesberg
authors.forename: M
authors.initials: M
authors.lastname: Velasco-Garrido
authors.forename: S
authors.initials: S
authors.lastname: Weinbrenner
authors.forename: C A
authors.initials: CA
authors.lastname: Gericke
authors.forename: R
authors.initials: R
authors.lastname: Busse
mesh_terms: D003363:Cost Control / Q000191:economics / Q000379:methods*; D003362:Cost-Benefit Analysis / Q000191:economics* / Q000379:methods*; D020000:Decision Support Systems, Clinical; D004358:Drug Therapy / Q000191:economics* / Q000379:methods*; D005858:Germany; D017048:Health Care Costs; D006801:Humans; D017059:Models, Econometric; D016896:Treatment Outcome